These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 24753526)

  • 1. Hemostatic abnormalities in Noonan syndrome.
    Artoni A; Selicorni A; Passamonti SM; Lecchi A; Bucciarelli P; Cerutti M; Cianci P; Gianniello F; Martinelli I
    Pediatrics; 2014 May; 133(5):e1299-304. PubMed ID: 24753526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hematological findings in Noonan syndrome.
    Bertola DR; Carneiro JD; D'Amico EA; Kim CA; Albano LM; Sugayama SM; Gonzalez CH
    Rev Hosp Clin Fac Med Sao Paulo; 2003; 58(1):5-8. PubMed ID: 12754583
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Children with hemorrhagic diathesis: correct diagnostic and therapeutic approach].
    Carnelli V; Dozzi M; Gibelli M; Giovanniello A; Riva F; Seidita C; Stucchi C
    Pediatr Med Chir; 1990; 12(1):1-13. PubMed ID: 2198546
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RASopathies and hemostatic abnormalities: key role of platelet dysfunction.
    Di Candia F; Marchetti V; Cirillo F; Di Minno A; Rosano C; Pagano S; Siano MA; Falco M; Assunto A; Boccia G; Magliacane G; Pinna V; De Luca A; Tartaglia M; Di Minno G; Strisciuglio P; Melis D
    Orphanet J Rare Dis; 2021 Dec; 16(1):499. PubMed ID: 34857025
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perioperative monitoring of primary and secondary hemostasis in coronary artery bypass grafting.
    Hertfelder HJ; Bös M; Weber D; Winkler K; Hanfland P; Preusse CJ
    Semin Thromb Hemost; 2005; 31(4):426-40. PubMed ID: 16149021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Measurement of bleeding time and study of thrombocyte aggregation. Standardization of methods, normal values and results in patients with suspected hemorrhagic diathesis].
    Thommen D; Sulzer I; Buhrfeind E; Naef R; Furlan M; Lämmle B
    Schweiz Med Wochenschr; 1988 Oct; 118(43):1559-67. PubMed ID: 3238391
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bleeding diathesis in Noonan syndrome: a common association.
    Witt DR; McGillivray BC; Allanson JE; Hughes HE; Hathaway WE; Zipursky A; Hall JG
    Am J Med Genet; 1988 Oct; 31(2):305-17. PubMed ID: 3232698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Imbalance of plasminogen activator inhibitor type-1 (PAI-1) and tissue plasminogen activator (t-PA) activity in patients with Noonan syndrome.
    Mehta P; Parker RI
    J Pediatr Hematol Oncol; 2010 Oct; 32(7):532-6. PubMed ID: 20686427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A longitudinal prospective study of bleeding diathesis in Egyptian pediatric patients: single-center experience.
    Mokhtar GM; Tantawy AA; Adly AA; Telbany MA; El Arab SE; Ismail M
    Blood Coagul Fibrinolysis; 2012 Jul; 23(5):411-8. PubMed ID: 22610136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Tendency toward bleeding in Noonan syndrome].
    Ruige P; van Oostrom C
    Tijdschr Kindergeneeskd; 1986 Aug; 54(4):107-11. PubMed ID: 3764876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bleeding diathesis in Noonan syndrome: is acquired von Willebrand syndrome the clue?
    Wiegand G; Hofbeck M; Zenker M; Budde U; Rauch R
    Thromb Res; 2012 Nov; 130(5):e251-4. PubMed ID: 22985731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prevalence of bleeding disorders among healthy pediatric patients with abnormal preprocedural coagulation studies.
    Shaw PH; Reynolds S; Gunawardena S; Krishnamurti L; Ritchey AK
    J Pediatr Hematol Oncol; 2008 Feb; 30(2):135-41. PubMed ID: 18376266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A patient with isolated prolongation of aPTT without hemorrhagic diathesis anamnesis: severe, hereditary factor XII deficiency].
    Zeerleder S; Asmis L; Redondo M; Sulzer I; Lämmle B
    Ther Umsch; 1999 Sep; 56(9):509-12. PubMed ID: 10517121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Thrombocyte dysfunction in children with albinism].
    Pap Z; Ajzner E; Kiss C; Emódy J; Závodszky I; Horváth A; Muszbek L
    Orv Hetil; 1997 Feb; 138(8):467-71. PubMed ID: 9139250
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coagulation-factor deficiencies and abnormal bleeding in Noonan's syndrome.
    Sharland M; Patton MA; Talbot S; Chitolie A; Bevan DH
    Lancet; 1992 Jan; 339(8784):19-21. PubMed ID: 1345952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolongation of the prothrombin time and activated partial thromboplastin time in children with sickle cell disease.
    Raffini LJ; Niebanck AE; Hrusovsky J; Stevens A; Blackwood-Chirchir A; Ohene-Frempong K; Kwiatkowski JL
    Pediatr Blood Cancer; 2006 Oct; 47(5):589-93. PubMed ID: 16123995
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of bleeding disorders in children with epistaxis: value of preoperative tests and clinical screening.
    Elden L; Reinders M; Witmer C
    Int J Pediatr Otorhinolaryngol; 2012 Jun; 76(6):767-71. PubMed ID: 22459034
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Noonan syndrome: partial factor XI deficiency.
    de Haan M; vd Kamp JJ; Briët E; Dubbeldam J
    Am J Med Genet; 1988 Feb; 29(2):277-82. PubMed ID: 3354599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noonan syndrome: coagulation and clinical aspects.
    Massarano AA; Wood A; Tait RC; Stevens R; Super M
    Acta Paediatr; 1996 Oct; 85(10):1181-5. PubMed ID: 8922080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemostatic abnormalities in patients with Ehlers-Danlos syndrome.
    Artoni A; Bassotti A; Abbattista M; Marinelli B; Lecchi A; Gianniello F; Clerici M; Bucciarelli P; La Marca S; Peyvandi F; Martinelli I
    J Thromb Haemost; 2018 Dec; 16(12):2425-2431. PubMed ID: 30312027
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.